| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bacteriophages | 16 | 2025 | 87 | 8.110 |
Why?
|
| Bacillus anthracis | 18 | 2021 | 40 | 6.270 |
Why?
|
| Phage Therapy | 10 | 2025 | 39 | 4.990 |
Why?
|
| Escherichia coli Infections | 16 | 2024 | 192 | 4.950 |
Why?
|
| Extraintestinal Pathogenic Escherichia coli | 7 | 2024 | 25 | 4.720 |
Why?
|
| Heme | 13 | 2019 | 52 | 4.000 |
Why?
|
| Bacterial Proteins | 19 | 2020 | 930 | 3.240 |
Why?
|
| Escherichia coli | 16 | 2024 | 995 | 3.150 |
Why?
|
| Anthrax | 8 | 2020 | 31 | 3.110 |
Why?
|
| Urinary Tract Infections | 5 | 2025 | 317 | 2.570 |
Why?
|
| Iron | 10 | 2015 | 302 | 2.180 |
Why?
|
| Bacterial Translocation | 4 | 2018 | 24 | 1.720 |
Why?
|
| Escherichia coli Vaccines | 2 | 2024 | 11 | 1.720 |
Why?
|
| Gene Library | 2 | 2024 | 213 | 1.680 |
Why?
|
| Anti-Bacterial Agents | 10 | 2025 | 2553 | 1.680 |
Why?
|
| Hemoglobins | 7 | 2021 | 322 | 1.600 |
Why?
|
| Bacterial Infections | 3 | 2025 | 323 | 1.510 |
Why?
|
| Microbial Viability | 4 | 2021 | 42 | 1.360 |
Why?
|
| Escherichia coli Proteins | 7 | 2024 | 316 | 1.290 |
Why?
|
| Bacterial Adhesion | 3 | 2020 | 106 | 1.250 |
Why?
|
| Intestines | 4 | 2021 | 606 | 1.220 |
Why?
|
| Anthrax Vaccines | 2 | 2020 | 26 | 1.180 |
Why?
|
| Reactive Oxygen Species | 3 | 2024 | 516 | 1.170 |
Why?
|
| Uropathogenic Escherichia coli | 2 | 2024 | 21 | 1.010 |
Why?
|
| Pseudomonas aeruginosa | 6 | 2023 | 175 | 1.010 |
Why?
|
| Virulence Factors | 9 | 2024 | 187 | 1.000 |
Why?
|
| Metabolome | 2 | 2021 | 324 | 0.990 |
Why?
|
| Bacteremia | 2 | 2023 | 428 | 0.980 |
Why?
|
| Bacterial Toxins | 6 | 2015 | 176 | 0.970 |
Why?
|
| Blood Proteins | 4 | 2021 | 136 | 0.940 |
Why?
|
| Aminoacyltransferases | 4 | 2015 | 8 | 0.940 |
Why?
|
| Measles virus | 1 | 2025 | 16 | 0.930 |
Why?
|
| Burkholderiales | 1 | 2025 | 1 | 0.930 |
Why?
|
| Polyethylene Terephthalates | 1 | 2025 | 30 | 0.920 |
Why?
|
| Hemolysin Proteins | 2 | 2024 | 29 | 0.910 |
Why?
|
| Measles | 1 | 2025 | 42 | 0.900 |
Why?
|
| ADP Ribose Transferases | 5 | 2006 | 20 | 0.900 |
Why?
|
| Heparan Sulfate Proteoglycans | 2 | 2021 | 17 | 0.860 |
Why?
|
| Gene Expression Regulation, Bacterial | 2 | 2024 | 173 | 0.860 |
Why?
|
| Antigens, Bacterial | 3 | 2024 | 324 | 0.860 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2024 | 61 | 0.840 |
Why?
|
| Metagenomics | 1 | 2024 | 106 | 0.840 |
Why?
|
| Enterohemorrhagic Escherichia coli | 3 | 2024 | 7 | 0.830 |
Why?
|
| Vibrio | 1 | 2023 | 9 | 0.820 |
Why?
|
| Pseudomonas Phages | 1 | 2023 | 10 | 0.820 |
Why?
|
| Poliovirus | 1 | 2023 | 47 | 0.810 |
Why?
|
| Animals | 28 | 2025 | 34850 | 0.810 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 3 | 2021 | 149 | 0.790 |
Why?
|
| Pseudomonas Infections | 1 | 2023 | 116 | 0.750 |
Why?
|
| Adhesins, Escherichia coli | 3 | 2020 | 21 | 0.740 |
Why?
|
| Hydro-Lyases | 1 | 2021 | 9 | 0.730 |
Why?
|
| Bacillus | 1 | 2021 | 37 | 0.730 |
Why?
|
| Bacteria | 4 | 2024 | 522 | 0.720 |
Why?
|
| Blood | 2 | 2021 | 103 | 0.720 |
Why?
|
| Carbon | 1 | 2021 | 94 | 0.700 |
Why?
|
| DNA Damage | 1 | 2024 | 511 | 0.700 |
Why?
|
| Viral Tail Proteins | 1 | 2021 | 6 | 0.700 |
Why?
|
| DNA Repair | 1 | 2024 | 567 | 0.690 |
Why?
|
| Microbial Interactions | 1 | 2021 | 16 | 0.690 |
Why?
|
| Organoids | 6 | 2021 | 299 | 0.690 |
Why?
|
| Cysteine Endopeptidases | 4 | 2015 | 112 | 0.690 |
Why?
|
| Antibodies, Bacterial | 2 | 2020 | 406 | 0.680 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2021 | 246 | 0.660 |
Why?
|
| Polysaccharides | 1 | 2021 | 148 | 0.640 |
Why?
|
| Humans | 49 | 2025 | 132256 | 0.640 |
Why?
|
| Biofilms | 4 | 2024 | 98 | 0.620 |
Why?
|
| Enterococcus faecalis | 2 | 2024 | 50 | 0.610 |
Why?
|
| Culture Media | 5 | 2021 | 182 | 0.600 |
Why?
|
| Fimbriae Proteins | 2 | 2021 | 22 | 0.600 |
Why?
|
| Fimbriae, Bacterial | 2 | 2020 | 44 | 0.590 |
Why?
|
| Protein Structure, Tertiary | 11 | 2019 | 764 | 0.590 |
Why?
|
| Host-Pathogen Interactions | 5 | 2024 | 263 | 0.590 |
Why?
|
| Gastrointestinal Tract | 1 | 2021 | 232 | 0.580 |
Why?
|
| Protein Binding | 10 | 2019 | 1734 | 0.580 |
Why?
|
| Mice | 14 | 2025 | 18507 | 0.580 |
Why?
|
| Tissue Preservation | 1 | 2018 | 16 | 0.580 |
Why?
|
| Coliphages | 1 | 2018 | 4 | 0.570 |
Why?
|
| Bacteriolysis | 1 | 2018 | 8 | 0.570 |
Why?
|
| Tissue Culture Techniques | 1 | 2018 | 68 | 0.570 |
Why?
|
| Gastric Mucosa | 1 | 2021 | 491 | 0.550 |
Why?
|
| Staining and Labeling | 1 | 2018 | 181 | 0.540 |
Why?
|
| Viral Tropism | 1 | 2018 | 53 | 0.540 |
Why?
|
| Metals | 1 | 2018 | 66 | 0.540 |
Why?
|
| Amino Acid Sequence | 10 | 2019 | 2669 | 0.530 |
Why?
|
| In Vitro Techniques | 1 | 2018 | 862 | 0.520 |
Why?
|
| Antibodies, Neutralizing | 1 | 2020 | 500 | 0.500 |
Why?
|
| Metalloproteins | 1 | 2015 | 11 | 0.480 |
Why?
|
| Phospholipases A2 | 1 | 2015 | 36 | 0.480 |
Why?
|
| Models, Biological | 4 | 2019 | 1445 | 0.470 |
Why?
|
| Cities | 3 | 2024 | 49 | 0.470 |
Why?
|
| Cytotoxins | 3 | 2004 | 23 | 0.460 |
Why?
|
| Mice, Inbred BALB C | 4 | 2021 | 1050 | 0.460 |
Why?
|
| Gram-Positive Bacteria | 2 | 2014 | 48 | 0.460 |
Why?
|
| Serum | 1 | 2015 | 43 | 0.460 |
Why?
|
| Zinc | 1 | 2015 | 125 | 0.460 |
Why?
|
| Intestinal Mucosa | 5 | 2021 | 797 | 0.460 |
Why?
|
| Molecular Sequence Data | 8 | 2015 | 3771 | 0.450 |
Why?
|
| Biosensing Techniques | 1 | 2015 | 67 | 0.450 |
Why?
|
| Virulence | 5 | 2024 | 279 | 0.430 |
Why?
|
| Cytoskeletal Proteins | 2 | 2006 | 282 | 0.420 |
Why?
|
| Type V Secretion Systems | 2 | 2024 | 8 | 0.420 |
Why?
|
| Microfilament Proteins | 2 | 2006 | 285 | 0.410 |
Why?
|
| Membrane Transport Proteins | 2 | 2012 | 182 | 0.400 |
Why?
|
| Methemoglobin | 1 | 2013 | 5 | 0.400 |
Why?
|
| Epithelial Cells | 1 | 2017 | 906 | 0.400 |
Why?
|
| Bilirubin | 1 | 2013 | 128 | 0.390 |
Why?
|
| Iron-Binding Proteins | 2 | 2012 | 33 | 0.380 |
Why?
|
| Genome, Viral | 3 | 2024 | 179 | 0.380 |
Why?
|
| Amino Acids | 1 | 2015 | 626 | 0.380 |
Why?
|
| Carrier Proteins | 3 | 2020 | 1050 | 0.370 |
Why?
|
| Cell Wall | 2 | 2009 | 41 | 0.370 |
Why?
|
| Public Health | 2 | 2025 | 280 | 0.360 |
Why?
|
| Glutamine | 1 | 2013 | 211 | 0.360 |
Why?
|
| Staphylococcus aureus | 4 | 2021 | 479 | 0.360 |
Why?
|
| Cell Culture Techniques | 3 | 2021 | 287 | 0.360 |
Why?
|
| Antioxidants | 1 | 2013 | 333 | 0.340 |
Why?
|
| Cattle | 3 | 2024 | 569 | 0.320 |
Why?
|
| Biological Transport | 4 | 2015 | 348 | 0.320 |
Why?
|
| Gene Deletion | 3 | 2021 | 794 | 0.310 |
Why?
|
| Drug Resistance, Bacterial | 3 | 2024 | 382 | 0.300 |
Why?
|
| Organ Culture Techniques | 2 | 2021 | 157 | 0.300 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2008 | 38 | 0.280 |
Why?
|
| Disease Models, Animal | 4 | 2024 | 4690 | 0.280 |
Why?
|
| Microbial Sensitivity Tests | 2 | 2021 | 827 | 0.280 |
Why?
|
| Gastrointestinal Microbiome | 3 | 2025 | 810 | 0.270 |
Why?
|
| Membrane Proteins | 2 | 2006 | 1597 | 0.270 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2008 | 79 | 0.270 |
Why?
|
| Protein Conformation | 4 | 2016 | 826 | 0.270 |
Why?
|
| Sequence Alignment | 4 | 2019 | 615 | 0.260 |
Why?
|
| Vaccination | 2 | 2023 | 1018 | 0.250 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 1829 | 0.230 |
Why?
|
| Adenosine Diphosphate | 2 | 2004 | 55 | 0.230 |
Why?
|
| Biodegradation, Environmental | 1 | 2025 | 13 | 0.230 |
Why?
|
| Seawater | 1 | 2024 | 14 | 0.230 |
Why?
|
| Neoplasms | 2 | 2021 | 2961 | 0.220 |
Why?
|
| Livestock | 1 | 2024 | 9 | 0.220 |
Why?
|
| Farmers | 1 | 2024 | 13 | 0.220 |
Why?
|
| Fresh Water | 1 | 2024 | 21 | 0.220 |
Why?
|
| Type III Secretion Systems | 1 | 2024 | 3 | 0.220 |
Why?
|
| Neutropenia | 2 | 2017 | 205 | 0.220 |
Why?
|
| Influenza in Birds | 1 | 2024 | 28 | 0.220 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 4 | 2006 | 69 | 0.220 |
Why?
|
| Epidemiological Monitoring | 1 | 2024 | 62 | 0.220 |
Why?
|
| Survival Analysis | 2 | 2020 | 1575 | 0.220 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2024 | 62 | 0.210 |
Why?
|
| Birds | 1 | 2024 | 86 | 0.210 |
Why?
|
| Prophages | 1 | 2023 | 6 | 0.210 |
Why?
|
| Open Reading Frames | 1 | 2024 | 218 | 0.210 |
Why?
|
| Phylogeny | 2 | 2024 | 763 | 0.210 |
Why?
|
| Symbiosis | 2 | 2022 | 103 | 0.210 |
Why?
|
| Adenine | 1 | 2024 | 120 | 0.210 |
Why?
|
| Female | 8 | 2025 | 70791 | 0.210 |
Why?
|
| Models, Molecular | 4 | 2016 | 1120 | 0.200 |
Why?
|
| Recombinant Proteins | 2 | 2006 | 1350 | 0.200 |
Why?
|
| DNA, Viral | 1 | 2024 | 492 | 0.200 |
Why?
|
| Semen | 1 | 2023 | 81 | 0.200 |
Why?
|
| Kinetics | 4 | 2011 | 1130 | 0.190 |
Why?
|
| Cephalosporins | 1 | 2023 | 139 | 0.190 |
Why?
|
| Probiotics | 1 | 2025 | 226 | 0.190 |
Why?
|
| Intestine, Small | 2 | 2021 | 309 | 0.190 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 2 | 2019 | 42 | 0.190 |
Why?
|
| Phosphoproteins | 1 | 2004 | 443 | 0.180 |
Why?
|
| Ketones | 2 | 2015 | 27 | 0.180 |
Why?
|
| Texas | 3 | 2025 | 3632 | 0.180 |
Why?
|
| Vaccines, Synthetic | 1 | 2023 | 322 | 0.180 |
Why?
|
| Disease Outbreaks | 1 | 2023 | 329 | 0.180 |
Why?
|
| Enteropathogenic Escherichia coli | 1 | 2021 | 6 | 0.180 |
Why?
|
| Genetic Fitness | 1 | 2021 | 36 | 0.170 |
Why?
|
| Adaptation, Biological | 1 | 2021 | 35 | 0.170 |
Why?
|
| Pandemics | 3 | 2025 | 1186 | 0.170 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2021 | 60 | 0.170 |
Why?
|
| Lung | 3 | 2021 | 1556 | 0.170 |
Why?
|
| Cell Line | 2 | 2018 | 2724 | 0.170 |
Why?
|
| Drug Antagonism | 1 | 2020 | 12 | 0.170 |
Why?
|
| Complement C5 | 1 | 2020 | 7 | 0.170 |
Why?
|
| Binding Sites | 4 | 2014 | 1256 | 0.170 |
Why?
|
| Freund's Adjuvant | 1 | 2020 | 27 | 0.170 |
Why?
|
| Alum Compounds | 1 | 2020 | 42 | 0.170 |
Why?
|
| Drug Synergism | 1 | 2020 | 235 | 0.160 |
Why?
|
| Decision Making | 1 | 2025 | 699 | 0.160 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 803 | 0.160 |
Why?
|
| Administration, Inhalation | 1 | 2020 | 190 | 0.160 |
Why?
|
| Transplant Recipients | 1 | 2021 | 225 | 0.160 |
Why?
|
| Listeria monocytogenes | 1 | 2019 | 32 | 0.150 |
Why?
|
| Dysentery, Bacillary | 1 | 2019 | 11 | 0.150 |
Why?
|
| Prosthesis-Related Infections | 1 | 2021 | 187 | 0.150 |
Why?
|
| Mixed Function Oxygenases | 1 | 2019 | 36 | 0.150 |
Why?
|
| Shigella flexneri | 1 | 2019 | 16 | 0.150 |
Why?
|
| Immunogenicity, Vaccine | 1 | 2020 | 114 | 0.150 |
Why?
|
| Microbiota | 2 | 2022 | 434 | 0.150 |
Why?
|
| Immunocompromised Host | 2 | 2021 | 308 | 0.150 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2024 | 946 | 0.150 |
Why?
|
| Colon | 1 | 2021 | 370 | 0.150 |
Why?
|
| Fluorescence | 2 | 2015 | 102 | 0.140 |
Why?
|
| Sequence Analysis, DNA | 1 | 2024 | 1803 | 0.140 |
Why?
|
| Precision Medicine | 1 | 2021 | 360 | 0.140 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2021 | 233 | 0.140 |
Why?
|
| Bacterial Load | 1 | 2018 | 33 | 0.140 |
Why?
|
| Influenza, Human | 1 | 2024 | 700 | 0.140 |
Why?
|
| Metabolomics | 1 | 2021 | 479 | 0.140 |
Why?
|
| DNA | 1 | 2023 | 1479 | 0.140 |
Why?
|
| Caco-2 Cells | 1 | 2017 | 94 | 0.140 |
Why?
|
| Spheroids, Cellular | 1 | 2017 | 63 | 0.140 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 107 | 0.130 |
Why?
|
| Caliciviridae Infections | 1 | 2021 | 361 | 0.130 |
Why?
|
| Epithelium | 1 | 2018 | 354 | 0.130 |
Why?
|
| Jejunum | 1 | 2017 | 131 | 0.130 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2021 | 377 | 0.130 |
Why?
|
| Phagocytes | 1 | 2016 | 24 | 0.130 |
Why?
|
| Gastrointestinal Diseases | 1 | 2021 | 356 | 0.130 |
Why?
|
| Prospective Studies | 2 | 2025 | 6569 | 0.130 |
Why?
|
| Norovirus | 1 | 2021 | 350 | 0.130 |
Why?
|
| Spleen | 1 | 2017 | 271 | 0.130 |
Why?
|
| Injections, Intramuscular | 1 | 2016 | 196 | 0.130 |
Why?
|
| Iron Chelating Agents | 1 | 2015 | 15 | 0.120 |
Why?
|
| Spores, Bacterial | 1 | 2015 | 24 | 0.120 |
Why?
|
| Protein Sorting Signals | 1 | 2015 | 41 | 0.120 |
Why?
|
| Biosynthetic Pathways | 1 | 2015 | 29 | 0.120 |
Why?
|
| Cryoelectron Microscopy | 1 | 2017 | 243 | 0.120 |
Why?
|
| Cloning, Molecular | 1 | 2016 | 811 | 0.120 |
Why?
|
| Male | 4 | 2023 | 65018 | 0.110 |
Why?
|
| GTPase-Activating Proteins | 3 | 2004 | 92 | 0.110 |
Why?
|
| Transcriptome | 1 | 2021 | 1125 | 0.110 |
Why?
|
| Pyridones | 1 | 2015 | 131 | 0.110 |
Why?
|
| Cytoskeleton | 2 | 2006 | 168 | 0.110 |
Why?
|
| Gene Fusion | 1 | 2014 | 60 | 0.110 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2013 | 310 | 0.110 |
Why?
|
| Protein Interaction Maps | 1 | 2014 | 90 | 0.110 |
Why?
|
| Luminescent Proteins | 1 | 2014 | 165 | 0.110 |
Why?
|
| HeLa Cells | 2 | 2006 | 731 | 0.100 |
Why?
|
| Bacillus cereus | 1 | 2013 | 11 | 0.100 |
Why?
|
| Electron Transport | 1 | 2013 | 57 | 0.100 |
Why?
|
| Cell Membrane Permeability | 1 | 2013 | 72 | 0.100 |
Why?
|
| Bile | 1 | 2013 | 46 | 0.100 |
Why?
|
| Immobilized Proteins | 1 | 2013 | 5 | 0.100 |
Why?
|
| Actins | 2 | 2006 | 334 | 0.100 |
Why?
|
| Molecular Weight | 2 | 2003 | 309 | 0.100 |
Why?
|
| Evolution, Molecular | 2 | 2024 | 700 | 0.100 |
Why?
|
| Oxyhemoglobins | 1 | 2013 | 25 | 0.100 |
Why?
|
| Gene Expression | 1 | 2017 | 1563 | 0.100 |
Why?
|
| Liver Transplantation | 1 | 2021 | 1103 | 0.100 |
Why?
|
| Base Sequence | 1 | 2017 | 2900 | 0.100 |
Why?
|
| Heart-Assist Devices | 1 | 2021 | 1085 | 0.100 |
Why?
|
| Protein Structure, Secondary | 1 | 2013 | 246 | 0.100 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 143 | 0.090 |
Why?
|
| Mice, Knockout | 1 | 2020 | 3868 | 0.090 |
Why?
|
| Crystallography, X-Ray | 1 | 2013 | 387 | 0.090 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 2442 | 0.090 |
Why?
|
| Amino Acid Substitution | 1 | 2013 | 409 | 0.090 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2012 | 117 | 0.090 |
Why?
|
| Stem Cells | 3 | 2021 | 733 | 0.090 |
Why?
|
| Siderophores | 1 | 2011 | 10 | 0.090 |
Why?
|
| Cell Survival | 1 | 2013 | 868 | 0.090 |
Why?
|
| Kidney | 1 | 2017 | 1338 | 0.080 |
Why?
|
| Surface Plasmon Resonance | 1 | 2010 | 53 | 0.080 |
Why?
|
| Molecular Structure | 1 | 2011 | 322 | 0.080 |
Why?
|
| Chromatography, Affinity | 1 | 2009 | 60 | 0.080 |
Why?
|
| Treatment Outcome | 1 | 2025 | 13030 | 0.080 |
Why?
|
| Macrophages | 1 | 2013 | 692 | 0.070 |
Why?
|
| Gene Expression Profiling | 1 | 2015 | 1883 | 0.070 |
Why?
|
| Heart Failure | 1 | 2021 | 2398 | 0.070 |
Why?
|
| Retrospective Studies | 2 | 2023 | 17396 | 0.070 |
Why?
|
| Dithiothreitol | 1 | 2007 | 11 | 0.070 |
Why?
|
| Cell Line, Tumor | 1 | 2015 | 3691 | 0.070 |
Why?
|
| Mutation | 1 | 2021 | 6250 | 0.070 |
Why?
|
| Alkenes | 1 | 2007 | 7 | 0.070 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2007 | 90 | 0.070 |
Why?
|
| CHO Cells | 2 | 2004 | 158 | 0.070 |
Why?
|
| Aged | 1 | 2025 | 21483 | 0.060 |
Why?
|
| Cricetinae | 2 | 2004 | 381 | 0.060 |
Why?
|
| Peptidoglycan | 1 | 2006 | 22 | 0.060 |
Why?
|
| Cysteine | 1 | 2007 | 142 | 0.060 |
Why?
|
| Plasmids | 2 | 2004 | 459 | 0.060 |
Why?
|
| Operon | 1 | 2006 | 48 | 0.060 |
Why?
|
| Computational Biology | 1 | 2011 | 876 | 0.060 |
Why?
|
| Drug Design | 1 | 2007 | 161 | 0.060 |
Why?
|
| Protein Kinase C | 1 | 2006 | 120 | 0.060 |
Why?
|
| Enzyme Activation | 1 | 2007 | 618 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 4758 | 0.060 |
Why?
|
| ADP-Ribosylation Factors | 1 | 2004 | 3 | 0.060 |
Why?
|
| Hypoxanthine | 1 | 2024 | 7 | 0.060 |
Why?
|
| Xanthine | 1 | 2024 | 6 | 0.060 |
Why?
|
| Tetanus Toxin | 1 | 2004 | 26 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2007 | 589 | 0.050 |
Why?
|
| Isoelectric Point | 1 | 2003 | 17 | 0.050 |
Why?
|
| Intracellular Fluid | 1 | 2003 | 21 | 0.050 |
Why?
|
| Cholic Acids | 1 | 2003 | 16 | 0.050 |
Why?
|
| Protein Denaturation | 1 | 2003 | 48 | 0.050 |
Why?
|
| Enterocytes | 1 | 2024 | 75 | 0.050 |
Why?
|
| Host Specificity | 1 | 2023 | 23 | 0.050 |
Why?
|
| Coculture Techniques | 1 | 2024 | 238 | 0.050 |
Why?
|
| GTP Phosphohydrolases | 1 | 2004 | 156 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2015 | 4720 | 0.050 |
Why?
|
| Enzyme Stability | 1 | 2002 | 59 | 0.050 |
Why?
|
| Urea | 1 | 2003 | 231 | 0.050 |
Why?
|
| Spike Glycoprotein, Coronavirus | 1 | 2024 | 204 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2006 | 1612 | 0.050 |
Why?
|
| Protein Transport | 1 | 2003 | 370 | 0.050 |
Why?
|
| Transfection | 1 | 2004 | 996 | 0.050 |
Why?
|
| Recombination, Genetic | 1 | 2023 | 441 | 0.050 |
Why?
|
| Compassionate Use Trials | 1 | 2022 | 16 | 0.050 |
Why?
|
| Water | 1 | 2023 | 195 | 0.050 |
Why?
|
| Calcitriol | 1 | 2021 | 65 | 0.040 |
Why?
|
| Proteoglycans | 1 | 2021 | 92 | 0.040 |
Why?
|
| Laminin | 1 | 2021 | 72 | 0.040 |
Why?
|
| Middle Aged | 1 | 2021 | 29026 | 0.040 |
Why?
|
| Palivizumab | 1 | 2021 | 48 | 0.040 |
Why?
|
| Urinary Bladder | 1 | 2022 | 255 | 0.040 |
Why?
|
| Mucins | 1 | 2021 | 72 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2021 | 280 | 0.040 |
Why?
|
| Hydrogels | 1 | 2021 | 108 | 0.040 |
Why?
|
| Substrate Specificity | 2 | 2015 | 301 | 0.040 |
Why?
|
| Viruses | 1 | 2021 | 126 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2021 | 237 | 0.040 |
Why?
|
| Collagen | 1 | 2021 | 303 | 0.040 |
Why?
|
| Perfusion | 1 | 2021 | 208 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2003 | 800 | 0.040 |
Why?
|
| Large Neutral Amino Acid-Transporter 1 | 1 | 2019 | 3 | 0.040 |
Why?
|
| Diarrhea | 1 | 2021 | 331 | 0.040 |
Why?
|
| Virus Diseases | 1 | 2021 | 289 | 0.040 |
Why?
|
| Crohn Disease | 1 | 2021 | 291 | 0.040 |
Why?
|
| Feces | 1 | 2021 | 753 | 0.030 |
Why?
|
| Virus Replication | 1 | 2021 | 636 | 0.030 |
Why?
|
| Cells, Cultured | 1 | 2021 | 3046 | 0.030 |
Why?
|
| Time Factors | 1 | 2004 | 6452 | 0.030 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2014 | 153 | 0.030 |
Why?
|
| Peptides | 1 | 2014 | 844 | 0.020 |
Why?
|
| Adult | 2 | 2021 | 31620 | 0.020 |
Why?
|
| Infant | 1 | 2021 | 13049 | 0.010 |
Why?
|
| Trypan Blue | 1 | 2004 | 4 | 0.010 |
Why?
|
| Adenosine Diphosphate Ribose | 1 | 2004 | 13 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 2004 | 92 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 206 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2004 | 651 | 0.010 |
Why?
|